Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Pharma
Pharma rebound puts Bayer split debate back on the table
The call for a two-way pharma-crop split has been on Bayer investors’ minds for at least eight years and apparently didn’t go away.
Angus Liu
Nov 3, 2026 11:27am
Bayer's Nubeqa eyes wider market after phase 3 win
Oct 24, 2026 8:30am
Melissa explains it all in menopause team up with Bayer
Oct 8, 2026 9:24am
Bayer doubles down on US with $2.2B Ohio manufacturing project
Oct 2, 2026 3:10pm
Bayer sells cancer drug Stivarga to Grünenthal for up to $431M
Sep 21, 2026 10:20am
Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes
Sep 17, 2026 2:06pm
